WUXI BIO, a leading biotech company, saw its stock surge 7.10% in Tuesday's intraday trading session as investors anticipated potential economic stimulus measures from Chinese policymakers.
According to the news report, China's top leaders are set to convene the annual Central Economic Work Conference next week to map out economic targets and stimulus plans for 2025. Investors are betting that authorities will announce supportive policies, such as a higher fiscal deficit target and increased government borrowing, to shore up the faltering economy.
The biotech sector, including WUXI BIO and its affiliate WUXI APPTEC, rallied on expectations that these potential stimulus measures could provide a boost to various industries, including healthcare and technology.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。